CN107973823A - The electroluminescent organic material of a kind of quinolyl dibenzo substitution as ligand and application thereof - Google Patents
The electroluminescent organic material of a kind of quinolyl dibenzo substitution as ligand and application thereof Download PDFInfo
- Publication number
- CN107973823A CN107973823A CN201610918184.9A CN201610918184A CN107973823A CN 107973823 A CN107973823 A CN 107973823A CN 201610918184 A CN201610918184 A CN 201610918184A CN 107973823 A CN107973823 A CN 107973823A
- Authority
- CN
- China
- Prior art keywords
- compound
- compound according
- filtrate
- yield
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003446 ligand Substances 0.000 title claims abstract description 13
- 238000006467 substitution reaction Methods 0.000 title claims abstract description 11
- 125000005493 quinolyl group Chemical group 0.000 title claims abstract description 6
- 239000011368 organic material Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 81
- 239000000463 material Substances 0.000 claims description 26
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 125000004404 heteroalkyl group Chemical group 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 125000001072 heteroaryl group Chemical group 0.000 claims description 4
- 150000002431 hydrogen Chemical class 0.000 claims description 4
- 229910052697 platinum Inorganic materials 0.000 claims description 4
- 229910052741 iridium Inorganic materials 0.000 claims description 3
- 125000001424 substituent group Chemical group 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 229910021645 metal ion Inorganic materials 0.000 claims description 2
- 229910052762 osmium Inorganic materials 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 229910052763 palladium Inorganic materials 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 229920001621 AMOLED Polymers 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 114
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 58
- 239000000706 filtrate Substances 0.000 description 58
- 230000015572 biosynthetic process Effects 0.000 description 42
- 239000007787 solid Substances 0.000 description 42
- 238000003786 synthesis reaction Methods 0.000 description 42
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 40
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 35
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- 229910052757 nitrogen Inorganic materials 0.000 description 29
- 239000000203 mixture Substances 0.000 description 28
- 238000006243 chemical reaction Methods 0.000 description 27
- 150000003839 salts Chemical class 0.000 description 26
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 23
- 238000004440 column chromatography Methods 0.000 description 22
- 239000000047 product Substances 0.000 description 22
- 239000000243 solution Substances 0.000 description 21
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 20
- 229940093475 2-ethoxyethanol Drugs 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- 239000012043 crude product Substances 0.000 description 18
- 239000003960 organic solvent Substances 0.000 description 18
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 16
- 238000001914 filtration Methods 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000003756 stirring Methods 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 239000011259 mixed solution Substances 0.000 description 13
- 238000000746 purification Methods 0.000 description 13
- 239000000741 silica gel Substances 0.000 description 13
- 229910002027 silica gel Inorganic materials 0.000 description 13
- 229920006395 saturated elastomer Polymers 0.000 description 11
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 10
- 238000005160 1H NMR spectroscopy Methods 0.000 description 9
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 9
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 239000010408 film Substances 0.000 description 9
- 239000012074 organic phase Substances 0.000 description 9
- 239000003208 petroleum Substances 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- 229910000029 sodium carbonate Inorganic materials 0.000 description 9
- 229910052938 sodium sulfate Inorganic materials 0.000 description 9
- 235000011152 sodium sulphate Nutrition 0.000 description 9
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 8
- 229910000024 caesium carbonate Inorganic materials 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 229910001868 water Inorganic materials 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- 229940125810 compound 20 Drugs 0.000 description 7
- 239000008367 deionised water Substances 0.000 description 7
- 229910021641 deionized water Inorganic materials 0.000 description 7
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 7
- LNJXVUXPFZKMNF-UHFFFAOYSA-K iridium(3+);trichloride;trihydrate Chemical compound O.O.O.Cl[Ir](Cl)Cl LNJXVUXPFZKMNF-UHFFFAOYSA-K 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 description 6
- 229940126214 compound 3 Drugs 0.000 description 6
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 5
- GJMUCDMIIVSROW-UHFFFAOYSA-N 2,8-dimethylnonane-4,6-dione Chemical compound CC(C)CC(=O)CC(=O)CC(C)C GJMUCDMIIVSROW-UHFFFAOYSA-N 0.000 description 5
- 101100221809 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cpd-7 gene Proteins 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 4
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 4
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 4
- 229940126657 Compound 17 Drugs 0.000 description 4
- 201000003207 Joubert syndrome 1 Diseases 0.000 description 4
- 229940125758 compound 15 Drugs 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000005401 electroluminescence Methods 0.000 description 4
- 239000012299 nitrogen atmosphere Substances 0.000 description 4
- 238000000859 sublimation Methods 0.000 description 4
- 230000008022 sublimation Effects 0.000 description 4
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 3
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 3
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 3
- JECYUBVRTQDVAT-UHFFFAOYSA-N 2-acetylphenol Chemical compound CC(=O)C1=CC=CC=C1O JECYUBVRTQDVAT-UHFFFAOYSA-N 0.000 description 3
- 101100506090 Caenorhabditis elegans hil-2 gene Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 229910021607 Silver chloride Inorganic materials 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- CZKMPDNXOGQMFW-UHFFFAOYSA-N chloro(triethyl)germane Chemical compound CC[Ge](Cl)(CC)CC CZKMPDNXOGQMFW-UHFFFAOYSA-N 0.000 description 3
- 229960003677 chloroquine Drugs 0.000 description 3
- 229940126543 compound 14 Drugs 0.000 description 3
- 229940126142 compound 16 Drugs 0.000 description 3
- 150000004696 coordination complex Chemical class 0.000 description 3
- 239000000539 dimer Substances 0.000 description 3
- 239000002019 doping agent Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 230000005281 excited state Effects 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 3
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 2
- 101100108853 Mus musculus Anp32e gene Proteins 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- 229940125797 compound 12 Drugs 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- UVNPEUJXKZFWSJ-LMTQTHQJSA-N (R)-N-[(4S)-8-[6-amino-5-[(3,3-difluoro-2-oxo-1H-pyrrolo[2,3-b]pyridin-4-yl)sulfanyl]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-yl]-2-methylpropane-2-sulfinamide Chemical compound CC(C)(C)[S@@](=O)N[C@@H]1COCC11CCN(CC1)c1cnc(Sc2ccnc3NC(=O)C(F)(F)c23)c(N)n1 UVNPEUJXKZFWSJ-LMTQTHQJSA-N 0.000 description 1
- GBBSAMQTQCPOBF-UHFFFAOYSA-N 2,4,6-trimethyl-1,3,5,2,4,6-trioxatriborinane Chemical compound CB1OB(C)OB(C)O1 GBBSAMQTQCPOBF-UHFFFAOYSA-N 0.000 description 1
- UCVINTIEPYMTAQ-UHFFFAOYSA-N 2-dibenzofuran-4-ylquinoline Chemical compound C1=CC=CC2=NC(C3=C4OC=5C(C4=CC=C3)=CC=CC=5)=CC=C21 UCVINTIEPYMTAQ-UHFFFAOYSA-N 0.000 description 1
- KFKSIUOALVIACE-UHFFFAOYSA-N 3-phenylbenzaldehyde Chemical compound O=CC1=CC=CC(C=2C=CC=CC=2)=C1 KFKSIUOALVIACE-UHFFFAOYSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- 101150037468 CPD1 gene Proteins 0.000 description 1
- ZZDHBSVRJNYYHF-UHFFFAOYSA-N Cc(cc1CO)cc2c1[o]c1c2cccc1 Chemical compound Cc(cc1CO)cc2c1[o]c1c2cccc1 ZZDHBSVRJNYYHF-UHFFFAOYSA-N 0.000 description 1
- 102100021704 Cytochrome P450 2D6 Human genes 0.000 description 1
- 101000896586 Homo sapiens Cytochrome P450 2D6 Proteins 0.000 description 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 1
- NUGPIZCTELGDOS-QHCPKHFHSA-N N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclopentanecarboxamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CC[C@@H](C=1C=NC=CC=1)NC(=O)C1CCCC1)C NUGPIZCTELGDOS-QHCPKHFHSA-N 0.000 description 1
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
- 101100165815 Oryza sativa subsp. japonica CYP90A3 gene Proteins 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 101100490727 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) AIF1 gene Proteins 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008358 core component Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 101150025236 dmaW gene Proteins 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 230000005525 hole transport Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- WRECIMRULFAWHA-UHFFFAOYSA-N trimethyl borate Chemical compound COB(OC)OC WRECIMRULFAWHA-UHFFFAOYSA-N 0.000 description 1
- 238000001771 vacuum deposition Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0033—Iridium compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/30—Coordination compounds
- H10K85/341—Transition metal complexes, e.g. Ru(II)polypyridine complexes
- H10K85/342—Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6574—Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6576—Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1092—Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/185—Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Optics & Photonics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Electroluminescent Light Sources (AREA)
Abstract
It is a kind of that compound of ligand and application thereof is used as using the substitution of quinolyl dibenzo.The compound has structure shown in Formulas I.Compound provided by the invention has the advantages that heat endurance is good, and luminous efficiency is high, long lifespan, can be used in organic luminescent device, especially as emitting red light doping body, has the possibility applied to AMOLED industries.
Description
Technical Field
The invention belongs to the field of electroluminescent materials, and particularly relates to an organic electroluminescent material taking quinolyl dibenzo substitution as a ligand and application thereof.
Background
The organic electroluminescence refers to a phenomenon that a thin film device prepared from an organic photoelectric functional material emits light under the excitation action of a field. The organic electroluminescent diode (OLED) and the polymer electroluminescent diode (PLED) may be classified according to the luminescent material used to prepare the functional thin film.
The OLED as a brand new display technology has the advantages that the existing display technology has no ethical ratio in all performances, such as full solid state, self-luminescence, high brightness, high resolution, wide viewing angle (more than 170 degrees), high response speed, thin thickness, small volume, light weight, capability of using a flexible substrate, low-voltage direct current driving (3-10V), low power consumption, wide working temperature range and the like, so that the OLED has a wide application market, such as an illumination system, a communication system, vehicle-mounted display, portable electronic equipment, high-definition display and even the military field.
The light emitting process of the OLED device is as follows, (1) injection of carriers: under the action of an external electric field, electrons and holes are respectively injected into the organic functional thin film layer clamped between the electrodes from the cathode and the anode; (2) migration of carriers: the injected electrons and holes respectively migrate from the electron transport layer and the hole transport layer to the light emitting layer; (3) recombination of carriers: the electrons and holes combine to generate excitons; (4) transfer of excitons: the excitons migrate under the action of an electric field, transfer energy to optical molecules, and excite electrons to transition from a ground state to an excited state; (5) electroluminescence: the excited state energy is deactivated by radiation, producing photons, releasing energy. When electrons and holes recombine in an organic molecule, two excited states, one approximately 25% singlet and one 75% triplet, are produced due to the difference in the electron spin symmetry.
The organic electroluminescent material is a core component of an organic electroluminescent device, and the thermal stability, photochemical stability, quantum efficiency, film forming property, crystallinity and the like of the material have great influence on the performance of the manufactured device, and can comprise fluorescent materials and phosphorescent materials.
It is generally believed that the fluorescent material is typically an organic small molecule material with a limit of 25% internal quantum efficiency, as CN105418582A discloses a high fluorescent material comprising a single (n ═ 0) or a series of (n ═ 1, 2, etc.) benzo-heterocycle systems. The phosphorescent material can utilize 75% of energy of triplet excitons due to spin-orbit coupling caused by the heavy atom effect, so that the luminous efficiency is improved without any problem. Compared with fluorescent materials, phosphorescent materials not only start late, but also have the problems of poor thermal stability, low luminous efficiency, short service life, low color saturation and the like, and are a very challenging problem up to now.
Disclosure of Invention
One of the objectives of the present invention is to provide a new compound of a heteroleptic complex with a quinolinyl dibenzo substituent as a ligand, which has the advantages of good thermal stability, high light-emitting efficiency, long lifetime, etc., and can be used in organic light-emitting devices, particularly as a red light-emitting dopant, with the possibility of being applied to AMOLED industry.
In order to achieve the purpose, the invention adopts the following technical scheme:
a compound using quinolyl dibenzo substitution as a ligand has a structure shown in formula I:
wherein,
z is selected from O, S, CR2, NR or Se, wherein R is alkyl, heteroalkyl, aryl or heteroaryl, and the like;
R1,R2,R3,R4each independently selected from hydrogen, alkyl, heteroalkyl, aryl or heteroaryl;
m is a metal;
X-Y is a monoanionic bidentate ligand;
the sum of a and b is the valence of the metal ion.
Preferably, the compound has the following formula II:
preferably, R1,R2,R3Each independently is hydrogen, mono-, di-or poly-substituted, preferably mono-substituted.
Preferably, R4Independently hydrogen or mono-or di-or polysubstituted, preferably hydrogen.
Preferably, R1,R2Independently a substituent or a fused ring structure with the parent.
Preferably, R1,R2,R3Independently an electron donating alkyl or heteroalkyl group of no more than four carbon atoms, preferably an electron donating branched alkyl group containing no more than 4 carbon atoms.
Preferably, R3The substitution position of (b) is an adjacent position of a metal-carbon bond.
Preferably, R3The substitution position of (b) is the relative position of the metal-carbon bond.
Preferably, M is a metal having an atomic coefficient of greater than 40, preferably Cu, Pt, Pd, Os, or Ir, more preferably Pt or Ir, and particularly preferably Ir.
X-Y may be the same as or different from the ligand on the left, and preferably X-Y is different from the ligand on the left. When X-Y is different from the main ligand on the left, X-Y is preferably of a 1, 3-diketone structure.
Preferably, the compound is of the structure:
preferably, the compound is of the structure:
it is also an object of the present invention to provide an OLED phosphorescent guest material comprising the above compound.
It is also an object of the present invention to provide an OLED device comprising the above-mentioned compound.
The material of the invention not only has higher luminous efficiency, but also has more saturated red color codes, and meanwhile, the service life of the device is longer. The metal complex of the present invention can convert triplet excitation energy into light as a guest material, and therefore, can be applied to display devices such as organic electroluminescence devices, and can improve the light emission efficiency of the devices, thereby reducing energy consumption. Meanwhile, the complex has the advantages of good stability, long service life, high color saturation and the like, and has good application prospect in the display device industries such as OLED and the like.
Detailed Description
For the purpose of facilitating an understanding of the present invention, the present invention will now be described by way of examples. It should be understood by those skilled in the art that the examples are only for the purpose of facilitating understanding of the present invention and should not be construed as specifically limiting the present invention.
The raw materials, acid-base catalysts and solvents involved in the synthesis of the compounds of the present invention are available from suppliers well known to those skilled in the art, such as carbofuran technology, Sigma, etc.
Example (b):
common intermediate synthesis as shown in the following 3:
synthesis of Compound 2:
compound 1(25.44g, 0.12mol, 1.2eq), 2-chloroquine (16.3g, 0.1mol, 1.0eq), Cs2CO3(97.5g, 0.3mol, 3.0eq), and Pd (dppf) Cl2(3.655g, 0.005mmol, 0.05eq) were charged in a 3L round bottom flask, 1L of anhydrous toluene was added, and stirring was refluxed at 110 ℃ for 16 hours under nitrogen. Then cooled to room temperature, concentrated under vacuum using a rotary evaporator to remove the organic solvent, the residue was dissolved in 1L of dichloromethane, 500ml of saturated aqueous sodium carbonate solution were slowly added, stirred, the layers were separated, and the organic phase was successively diluted with saturated sodium carbonate (300 ml. times.3), H2Washing with O (300ml of 3) and saturated sodium chloride (300ml of 3), drying with sodium sulfate, filtering, concentrating the filtrate in vacuo using a rotary evaporator to remove the organic solvent and obtain the crude product, and adding acetic acidThe crude product was purified by column chromatography using ethyl ester/petroleum ether (volume ratio 1:2) as the mobile phase and dried under vacuum at 50 ℃ to give compound 2(25.5g, yield: 86.44%).
As a result:
yield: 86.44 percent.
MS:m/z=296.1(M+H+);1HNMR(400M,d6-DMSO):8.06(dd,1H),7.93(dd,1H),7.62-7.73(m,3H),7.42-7.51(m,5H),7.14-7.25(m,3H).Anal.Calcd for C21H13NO:C,85.40;H,4.44;N,4.74.Found:C,85.39;H,4.45;N,4.73。
Synthesis of Compound 3:
2- (4-Dibenzofuranyl) quinoline (Compound 2) (8.85g, 0.03mol, 3.0eq) and iridium trichloride trihydrate (3.52g, 0.01mol, 1.0eq) were placed in a three-necked flask, 2-ethoxyethanol (66.7ml) and deionized water (33.3ml) were added, and the resulting mixture was reacted for 16hrs under nitrogen protection at about 110 ℃. Cooled to room temperature, filtered, and the filtrate was skimmed off, and the residue was dried with methanol (50 ml. times.3) and n-hexane (50 ml. times.3) in this order to give Compound 3(5.45g, yield: 66.75%) as a gray solid. The obtained compound 3 was used in the next step without purification.
Example 1 synthesis of compound CPD 1:
the dichloro bridge complex compound 3(4.08g, 2.5mmol, 1.0eq) was dissolved in 2-ethoxyethanol (25ml), anhydrous sodium carbonate (6.9g, 50mmol, 20.0eq) and acetylacetone (2.5g, 25mmol, 10.0eq) were added in this order, and after the addition was completed, the reaction was carried out at 30 ℃ for 16hrs under nitrogen protection, and then cooled to room temperature. 1g C salt and 200ml dichloromethane are added into the reaction solution to dissolve the product, then the mixed solution is filtered through a C salt bed, the filtrate is filtered through a short silica gel column, most dichloromethane is removed from the obtained filtrate, 30ml isopropanol is added into the filtrate, a red solid is separated out, and the red solid is filtered. The solid is separated by column chromatography to obtain the target complex CPD 1. (2.03g, yield: 46.1%).
Results of CPD1 yield: 46.1 percent. MS M/z 881.2(M + H +).
Example 2 synthesis of compound CPD 2:
the dichloro bridge complex compound 3(4.08g, 2.5mmol, 1.0eq) was dissolved in 2-ethoxyethanol (25ml), anhydrous sodium carbonate (6.9g, 50mmol, 20.0eq) and 2, 8-dimethylnonane-4, 6-dione (4.6g, 25mmol, 10.0eq) were added in this order, and after the addition was completed, the mixture was reacted at 30 ℃ for 16hrs under nitrogen protection, and then cooled to room temperature. Adding 1g of C salt and 200ml of dichloromethane into the reaction solution to dissolve the product, then filtering the mixed solution through a C salt bed, filtering the filtrate through a short silica gel column to obtain a filtrate, removing most of dichloromethane, adding 30ml of isopropanol into the filtrate to precipitate a red solid, and filtering. The solid is separated by column chromatography to obtain the target complex CPD 2. (1.98g, yield: 41.1%).
Results of CPD2 yield: 41.1 percent. MS M/z 965.3(M + H +).
Example 3 synthesis of compound CPD 3:
the dichloro bridge complex compound 3(4.08g, 2.5mmol, 1.0eq) was dissolved in 2-ethoxyethanol (25ml), anhydrous sodium carbonate (6.9g, 50mmol, 20.0eq) and 2-acetylphenol (3.4g, 25mmol, 10.0eq) were added in this order, and after the addition was completed, the mixture was reacted at 30 ℃ for 16hrs under nitrogen protection, and then cooled to room temperature. 1g C salt and 200ml dichloromethane are added into the reaction solution to dissolve the product, then the mixed solution is filtered through a C salt bed, the filtrate is filtered through a short silica gel column, most dichloromethane is removed from the obtained filtrate, 30ml isopropanol is added into the filtrate, a red solid is separated out, and the red solid is filtered. The solid is separated by column chromatography to obtain the target complex CPD 3. (1.58g, yield: 34.5%).
Results of CPD3 yield: 34.5 percent. MS M/z 917.2(M + H +).
Example 4 synthesis of compound CPD 4:
the first step is as follows: synthesis of triflate
Dimer compound 3(32.64g, 0.02mol, 1.0eq) was dissolved in 1L of dichloromethane, to which was added silver trifluoromethanesulfonate (10.5g, 0.04mol, 2.0eq) and isopropanol (75ml) in that order. The mixture was stirred at room temperature overnight. The silver chloride was filtered off and the filtrate was spin dried to give 41g of product, which was used directly in the next reaction without purification.
The second step is that: synthesis of Compound CPD4
The product of the first step (21.0g, 0.02mol, 1.0eq) and 2-phenylpyridine (9.3g, 0.06mol, 3.0eq) were dissolved in 200ml of anhydrous ethanol, and the mixture was heated under reflux overnight under a nitrogen atmosphere. After the reaction solution was cooled to room temperature, the precipitate was filtered and washed with methanol and n-hexane in sequence for 3 times. After drying at 50 ℃ in vacuo, the title compound CPD4(14.6g, yield 78.1%) was obtained. The dried CPD4 was used directly for sublimation purification to give the pure objective compound CPD4(10.1g, 69.18% yield) as a sublimated product.
Synthesis of common intermediates as shown in the following 9:
synthesis of Compound 6
Compound 5(24.59g, 0.1mol, 1.0eq), trimethylcyclotriboroxane (15.1g, 0.12mol, 1.2eq), Cs2CO3(97.5g, 0.3mol, 3.0eq), and Pd (dppf) Cl2(3.655g, 0.005mmol, 0.05eq) were charged in a 3L round bottom flask, 1L of anhydrous toluene was added, and stirring was refluxed at 110 ℃ for 16 hours under nitrogen. Subsequently, the mixture was cooled to room temperature, concentrated under vacuum using a rotary evaporator to remove the organic solvent, the residue was dissolved in 1L of dichloromethane, 500ml of a saturated aqueous solution of sodium carbonate was slowly added, stirred, and the layers were separated, the organic phase was washed with saturated sodium carbonate (300 ml. times.3), H2O (300 ml. times.3), and saturated sodium chloride (300 ml. times.3) in this order, dried over sodium sulfate and filtered, the filtrate was concentrated under vacuum using a rotary evaporator to remove the organic solvent and obtain a crude product, and the obtained crude product was purified by column chromatography using ethyl acetate/petroleum ether (volume ratio 1:5) as a mobile phase, and dried under vacuum at 50 ℃ to obtain Compound 6(14.7g, yield: 80.77%).
As a result:
yield: 80.77 percent.
MS:m/z=183.1(M+H+);1HNMR(400M,d6-DMSO):7.49(d,1H),7.4(dd,1H),7.28-7.30(m,2H),6.99-7.2(m,3H),2.35(s,3H).Anal.Calcd for C13H10O:C,85.69;H,5.53.Found:C,85.68;H,5.54。
Synthesis of Compound 7
In a 2L three-necked flask, compound 6(18.2g, 0.1mol, 1.0eq) was dissolved in 225ml of anhydrous tetrahydrofuran, the reaction solution was cooled to-78 ℃ under nitrogen protection, 125ml (0.2mol) of a 1.6mol/L solution of BuLi in hexane was slowly added to the mixture, and the mixture was stirred at-78 ℃ for 30min under nitrogen protection. After naturally returning to room temperature, the reaction was stirred overnight. The reaction mixture was cooled again to-78 ℃ and 33.75ml (0.3mol, 3.0eq) of trimethyl borate was slowly added and stirred at room temperature for 4 hours. 800ml of 1mol/L HCl solution are slowly added and stirring is continued for 1 hour. Vacuum concentration was performed using a rotary evaporator to remove the organic solvent, the residue was dissolved in 1L of dichloromethane, 300ml of saturated aqueous sodium carbonate solution was slowly added, stirring was performed, the layers were separated, the organic phase was washed with saturated sodium carbonate (300 ml. times.2), H2O (300 ml. times.3) and saturated sodium chloride (300 ml. times.3) in this order, dried over sodium sulfate and filtered, the filtrate was vacuum concentrated using a rotary evaporator to remove the organic solvent and obtain a crude product, the obtained crude product was purified by column chromatography using ethyl acetate/petroleum ether (volume ratio 1:5) as a mobile phase, and dried under vacuum at 50 ℃ to obtain Compound 7(17.8g, yield: 78.77%).
As a result:
yield: 78.77 percent.
MS:m/z=227.1(M+H+);1HNMR(400M,d6-DMSO):7.49(dd,1H),7.4(dd,1H),7.28-7.30(m,4H),2.32(s,3H).Anal.Calcd for C13H11BO3:C,69.08;H,4.91.Found:C,69.08;H,4.91。
Synthesis of Compound 8
Compound 7(27.12g, 0.12mol, 1.2eq), 2-chloroquine (16.3g, 0.1mol, 1.0eq), Cs2CO3(97.5g, 0.3mol, 3.0eq), and Pd (dppf) Cl2(3.655g, 0.005mmol, 0.05eq) were charged in a 3L round bottom flask, 1L of anhydrous toluene was added, and stirring was refluxed at 110 ℃ for 16 hours under nitrogen. Subsequently, the mixture was cooled to room temperature, and vacuum-concentrated using a rotary evaporator to remove the organic solvent, the residue was dissolved in 1L of dichloromethane, 500ml of a saturated aqueous solution of sodium carbonate was slowly added, stirring was carried out, the layers were separated, the organic phase was washed successively with saturated sodium carbonate (300 ml. times.3), H2O (300 ml. times.3) and saturated sodium chloride (300 ml. times.3), sodium sulfate was dried and then filtered, the filtrate was vacuum-concentrated using a rotary evaporator to remove the organic solvent and obtain a crude product, and the obtained crude product was purified by column chromatography using ethyl acetate/petroleum ether (volume ratio 1:2) as a mobile phase and vacuum-dried at 50 ℃ to obtain Compound 8(25.78g, yield: 83.4%).
As a result:
yield: 83.4 percent.
MS:m/z=310.1(M+H+);1HNMR(400M,d6-DMSO):8.05(dd,1H),7.92(dd,1H),7.62-7.73(m,3H),7.42-7.51(m,5H),7.14-7.25(m,2H),2.35(s,3H).Anal.Calcd forC22H15NO:C,85.41;H,4.89;N,4.53.Found:C,85.41;H,4.89;N,4.53。
Synthesis of Compound 9
2- (4- (2-methyldibenzofuranyl)) quinoline (Compound 8) (9.27g, 0.03mol, 3.0eq) and iridium trichloride trihydrate (3.52g, 0.01mol, 1.0eq) were placed in a three-necked flask, 2-ethoxyethanol (66.7ml) and deionized water (33.3ml) were added, and the resulting mixture was reacted for 16hrs under a nitrogen blanket at about 110 ℃. Cooled to room temperature, filtered, and the filtrate was skimmed off, and the residue was dried with methanol (50 ml. times.3) and n-hexane (50 ml. times.3) in this order to give compound 9(5.15g, yield: 60.9%) as a gray solid. The obtained compound 9 was used in the next step without purification.
EXAMPLE 5 Synthesis of Compound CPD5
The dichloro bridge complex compound 9(4.23g, 2.5mmol, 1.0eq) was dissolved in 2-ethoxyethanol (25ml), anhydrous sodium carbonate (6.9g, 50mmol, 20.0eq) and acetylacetone (2.5g, 25mmol, 10.0eq) were added in this order, and after the addition was completed, the reaction was carried out at 30 ℃ for 16hrs under nitrogen protection, and then cooled to room temperature. 1g C salt and 200ml dichloromethane are added into the reaction solution to dissolve the product, then the mixed solution is filtered through a C salt bed, the filtrate is filtered through a short silica gel column, most dichloromethane is removed from the obtained filtrate, 30ml isopropanol is added into the filtrate, a red solid is separated out, and the red solid is filtered. The solid is separated by column chromatography to obtain the target complex CPD 5. (2.06g, yield: 45.3%).
Results of CPD5 yield: 45.3 percent. MS M/z 909.2(M + H +).
Example 6 synthesis of compound CPD 6:
the dichloro bridge complex compound 9(4.23g, 2.5mmol, 1.0eq) was dissolved in 2-ethoxyethanol (25ml), anhydrous sodium carbonate (6.9g, 50mmol, 20.0eq) and 2, 8-dimethylnonane-4, 6-dione (4.6g, 25mmol, 10.0eq) were added in this order, and after the addition was complete, the reaction was carried out at 30 ℃ for 16hrs under nitrogen protection, and then cooled to room temperature. Adding 1g of C salt and 200ml of dichloromethane into the reaction solution to dissolve the product, then filtering the mixed solution through a C salt bed, filtering the filtrate through a short silica gel column to obtain a filtrate, removing most of dichloromethane, adding 30ml of isopropanol into the filtrate to precipitate a red solid, and filtering. The solid is separated by column chromatography to obtain the target complex CPD 6. (1.98g, yield: 39.8%).
Results of CPD6 yield: 39.8 percent. MS M/z 993.3(M + H +).
EXAMPLE 7 Synthesis of Compound CPD7
The dichloro bridge complex compound 9(4.23g, 2.5mmol, 1.0eq) was dissolved in 2-ethoxyethanol (25ml), anhydrous sodium carbonate (6.9g, 50mmol, 20.0eq) and 2-acetylphenol (3.4g, 25mmol, 10.0eq) were added in this order, and after the addition was completed, the mixture was reacted at 30 ℃ for 16hrs under nitrogen protection, and then cooled to room temperature. 1g C salt and 200ml dichloromethane are added into the reaction solution to dissolve the product, then the mixed solution is filtered through a C salt bed, the filtrate is filtered through a short silica gel column, most dichloromethane is removed from the obtained filtrate, 30ml isopropanol is added into the filtrate, a red solid is separated out, and the red solid is filtered. The solid is separated by column chromatography to obtain the target complex CPD 7. (1.51g, yield: 31.9%).
Results of CPD7 yield: 31.9 percent. MS M/z 945.2(M + H +).
EXAMPLE 8 Synthesis of Compound CPD8
The first step is as follows: synthesis of triflate
Dimer compound 9(33.78g, 0.02mol, 1.0eq) was dissolved in 1L of dichloromethane, to which was added silver trifluoromethanesulfonate (10.5g, 0.04mol, 2.0eq) and isopropanol (75ml) in that order. The mixture was stirred at room temperature overnight. The silver chloride was filtered off and the filtrate was spin dried to give 42g of product, which was used in the next reaction without purification.
The second step is that: synthesis of Compound CPD8
The product of the first step (21.56g, 0.02mol, 1.0eq) and 2-phenylpyridine (9.3g, 0.06mol, 3.0eq) were dissolved in 200ml of anhydrous ethanol, and the mixture was heated under reflux overnight under a nitrogen atmosphere. After the reaction solution was cooled to room temperature, the precipitate was filtered and washed with methanol and n-hexane in sequence for 3 times. After drying at 50 ℃ in vacuo, the title compound CPD8(13.2g, yield 68.5%) was obtained. The dried CPD8 was used directly for sublimation purification to give the pure objective compound CPD8(10.8g, 81.82% yield) as a sublimated product.
EXAMPLE 9 Synthesis of Compound CPD9
Synthesis of Compound 10
Compound 7(27.12g, 0.12mol, 1.2eq), 2-chloro-5-isobutylquinaline (21.9g, 0.1mol, 1.0eq), Cs2CO3(97.5g, 0.3mol, 3.0eq) and Pd (dppf) Cl2(3.655g, 0.005mmol, 0.05eq) were charged into a 3L round-bottomed flask, 1L of anhydrous toluene was added, and stirring was refluxed at 110 ℃ for 16 hours under nitrogen. Subsequently, the mixture was cooled to room temperature, concentrated under vacuum using a rotary evaporator to remove the organic solvent, the residue was dissolved in 1L of dichloromethane, 500ml of a saturated aqueous solution of sodium carbonate was slowly added, stirred, and the layers were separated, the organic phase was washed with saturated sodium carbonate (300 ml. times.3), H2O (300 ml. times.3), and saturated sodium chloride (300 ml. times.3) in this order, dried over sodium sulfate and filtered, the filtrate was concentrated under vacuum using a rotary evaporator to remove the organic solvent and obtain a crude product, and the obtained crude product was purified by column chromatography using ethyl acetate/petroleum ether (volume ratio 1:3) as a mobile phase, and dried under vacuum at 50 ℃ to obtain Compound 10(25.78g, yield: 70.63%).
As a result:
yield: 70.63 percent.
MS:m/z=366.2(M+H+);1HNMR(400M,d6-DMSO):7.89(dd,1H),7.82(dd,1H),7.72(s,1H),7.41-7.51(m,4H),7.31(s,1H),7.14-7.21(m,3H),2.51(d,2H),2.35(s,3H),2.22(m,1H),1.01(d,6H).Anal.Calcd for C26H23NO:C,85.45;H,6.34;N,3.83.Found:C,85.45;H,6.34;N,3.83。
Synthesis of compound 11:
2- (4- (2-methyldibenzofuranyl)) -5-isobutylquinoline (compound 10) (10.96g, 0.03mol, 3.0eq) and iridium trichloride trihydrate (3.52g, 0.01mol, 1.0eq) were placed in a three-necked flask, 2-ethoxyethanol (66.7ml) and deionized water (33.3ml) were added, and the resulting mixture was reacted for 16hrs at about 110 ℃ under nitrogen protection. Cooled to room temperature, filtered, and the filtrate was skimmed off, and the residue was dried with methanol (50 ml. times.3) and n-hexane (50 ml. times.3) in this order to give Compound 11 as a gray solid (5.64g, yield: 58.9%). The obtained compound 11 was used in the next step without purification.
Synthesis of compound CPD 9:
the dichloro bridge complex compound 11(4.78g, 2.5mmol, 1.0eq) was dissolved in 2-ethoxyethanol (25ml), anhydrous sodium carbonate (6.9g, 50mmol, 20.0eq) and acetylacetone (2.5g, 25mmol, 10.0eq) were added successively, and after completion of the addition, the reaction was carried out at 30 ℃ for 16hrs under nitrogen protection, and then cooled to room temperature. 1g C salt and 200ml dichloromethane are added into the reaction solution to dissolve the product, then the mixed solution is filtered through a C salt bed, the filtrate is filtered through a short silica gel column, most dichloromethane is removed from the obtained filtrate, 30ml isopropanol is added into the filtrate, a red solid is separated out, and the red solid is filtered. The solid is separated by column chromatography to obtain the target complex CPD 9. (1.84g, yield: 36.01%).
Results of CPD9 yield: 36.01 percent. MS M/z 1021.4(M + H +).
EXAMPLE 10 Synthesis of Compound CPD13
Synthesis of compound 12:
compound 7(27.12g, 0.12mol, 1.2eq), 2-chloro-7-isobutylquinacrine (21.9g, 0.1mol, 1.0eq), Cs2CO3(97.5g, 0.3mol, 3.0eq) and Pd (dppf) Cl2(3.655g, 0.005mmol, 0.05eq) were charged into a 3L round-bottomed flask, 1L of anhydrous toluene was added, and stirring was refluxed at 110 ℃ for 16 hours under nitrogen. Subsequently, the mixture was cooled to room temperature, and vacuum-concentrated using a rotary evaporator to remove the organic solvent, the residue was dissolved in 1L of dichloromethane, 500ml of a saturated aqueous solution of sodium carbonate was slowly added, stirring was carried out, the layers were separated, the organic phase was washed successively with saturated sodium carbonate (300 ml. times.3), H2O (300 ml. times.3) and saturated sodium chloride (300 ml. times.3), sodium sulfate was dried and then filtered, the filtrate was vacuum-concentrated using a rotary evaporator to remove the organic solvent and obtain a crude product, and the obtained crude product was purified by column chromatography using ethyl acetate/petroleum ether (volume ratio 1:3) as a mobile phase and vacuum-dried at 50 ℃ to obtain Compound 13(24.26g, yield: 66.5%).
As a result:
yield: 66.5 percent.
MS:m/z=366.2(M+H+);1HNMR(400M,d6-DMSO):7.85(dd,1H),,7.72-7.75(m,2H),7.62(d,1H),7.42-7.59(m,2H),7.29-7.38(m,3H),7.14-7.21(dd,2H),2.51(d,2H),2.35(s,3H),2.22(m,1H),1.01(d,6H).Anal.Calcd for C26H23NO:C,85.45;H,6.34;N,3.83.Found:C,85.45;H,6.34;N,3.83。
Synthesis of compound 13:
2- (4- (2-methyldibenzofuranyl)) -7-isobutylquinoline (compound 12) (10.96g, 0.03mol, 3.0eq) and iridium trichloride trihydrate (3.52g, 0.01mol, 1.0eq) were placed in a three-necked flask, 2-ethoxyethanol (66.7ml) and deionized water (33.3ml) were added, and the resulting mixture was reacted for 16hrs at about 110 ℃ under nitrogen protection. Cooled to room temperature, filtered, and the filtrate was skimmed off, and the residue was dried with methanol (50 ml. times.3) and n-hexane (50 ml. times.3) in this order to give compound 13(5.5g, yield: 57.4%) as a gray solid. The obtained compound 13 was used in the next step without purification.
Synthesis of compound CPD 13:
the dichloro bridge complex compound 13(4.78g, 2.5mmol, 1.0eq) was dissolved in 2-ethoxyethanol (25ml), anhydrous sodium carbonate (6.9g, 50mmol, 20.0eq) and acetylacetone (2.5g, 25mmol, 10.0eq) were added successively, and after the addition was completed, the reaction was carried out at 30 ℃ for 16hrs under nitrogen protection, and then cooled to room temperature. 1g C salt and 200ml dichloromethane are added into the reaction solution to dissolve the product, then the mixed solution is filtered through a C salt bed, the filtrate is filtered through a short silica gel column, most dichloromethane is removed from the obtained filtrate, 30ml isopropanol is added into the filtrate, a red solid is separated out, and the red solid is filtered. The solid is separated by column chromatography to obtain the target complex CPD 13. (1.56g, yield: 30.53%).
Results of CPD13 yield: 30.53 percent. MS M/z 1021.4(M + H +).
Example 11 synthesis of compound CPD 18:
synthesis of compound 14:
compound 7(27.12g, 0.12mol, 1.2eq), 2-chloro-4-isobutyl-6-methyl-quinaline (23.3g, 0.1mol, 1.0eq), Cs2CO3(97.5g, 0.3mol, 3.0eq) and Pd (dppf) Cl2(3.655g, 0.005mmol, 0.05eq) were charged into a 3L round-bottomed flask, 1L of anhydrous toluene was added, and stirring was refluxed at 110 ℃ for 16 hours under nitrogen. Subsequently, the mixture was cooled to room temperature, and vacuum-concentrated using a rotary evaporator to remove the organic solvent, the residue was dissolved in 1L of dichloromethane, 500ml of a saturated aqueous solution of sodium carbonate was slowly added, stirring was carried out, the layers were separated, the organic phase was washed successively with saturated sodium carbonate (300 ml. times.3), H2O (300 ml. times.3) and saturated sodium chloride (300 ml. times.3), sodium sulfate was dried and then filtered, the filtrate was vacuum-concentrated using a rotary evaporator to remove the organic solvent and obtain a crude product, and the obtained crude product was purified by column chromatography using ethyl acetate/petroleum ether (volume ratio 1:3) as a mobile phase and vacuum-dried at 50 ℃ to obtain Compound 14(26.42g, yield: 69.5%).
As a result:
yield: 69.5 percent.
MS:m/z=380.2(M+H+);1HNMR(400M,d6-DMSO):7.95(d,1H),7.72(s,1H),7.41-7.51(m,4H),7.31(s,1H),7.14-7.21(m,3H),2.51(d,2H),2.35(s,3H),2.31(s,3H),2.22(m,1H),1.01(d,6H).Anal.Calcd for C27H25NO:C,85.45;H,6.64;N,3.69.Found:C,85.45;H,6.64;N,3.69。
Synthesis of compound 15:
2- (4- (2-methyldibenzofuranyl)) -4-isobutyl-6-methylquinoline (compound 14) (11.38g, 0.03mol, 3.0eq) and iridium trichloride trihydrate (3.52g, 0.01mol, 1.0eq) were placed in a three-necked flask, 2-ethoxyethanol (66.7ml) and deionized water (33.3ml) were added, and the resulting mixture was reacted for 16hrs under a nitrogen blanket at about 110 ℃. Cooled to room temperature, filtered, and the filtrate was skimmed off, and the residue was dried with methanol (50 ml. times.3) and n-hexane (50 ml. times.3) in this order to give compound 15(5.18g, yield: 52.6%) as a gray solid. The obtained compound 15 was used in the next step without purification.
Synthesis of compound CPD 18:
dissolving the dichloro-bridge complex compound 15(4.93g, 2.5mmol, 1.0eq) in 2-ethoxyethanol (25ml), adding anhydrous sodium carbonate (6.9g, 50mmol, 20.0eq) and 2, 8-dimethyl nonane-4, 6-dione (4.6g, 25mmol, 10.0eq) in sequence, reacting at 30 ℃ for 16hrs under the protection of nitrogen after the addition is finished, and cooling to room temperature. Adding 1g of C salt and 200ml of dichloromethane into the reaction solution to dissolve the product, then filtering the mixed solution through a C salt bed, filtering the filtrate through a short silica gel column to obtain a filtrate, removing most of dichloromethane, adding 30ml of isopropanol into the filtrate to precipitate a red solid, and filtering. The solid is separated by column chromatography to obtain the target complex CPD 18. (1.80g, yield: 34.31%).
Results of CPD18 yield: 34.31 percent. MS M/z 1133.5(M + H +).
EXAMPLE 12 Synthesis of Compound CPD22
Synthesis of compound 16:
compound 7(27.12g, 0.12mol, 1.2eq), 2-chloro-4-methyl-7-isobutylquinaline (23.3g, 0.1mol, 1.0eq), and Cs2CO3(97.5g, 0.3mol, 3.0eq) and Pd (dppf) Cl2(3.655g, 0.005mmol, 0.05eq) were charged into a 3L round-bottomed flask, 1L of anhydrous toluene was added, and stirring was refluxed at 110 ℃ for 16 hours under nitrogen. Subsequently, the mixture was cooled to room temperature, and vacuum-concentrated using a rotary evaporator to remove the organic solvent, the residue was dissolved in 1L of dichloromethane, 500ml of a saturated aqueous solution of sodium carbonate was slowly added, stirring was carried out, the layers were separated, the organic phase was washed successively with saturated sodium carbonate (300 ml. times.3), H2O (300 ml. times.3) and saturated sodium chloride (300 ml. times.3), sodium sulfate was dried and then filtered, the filtrate was vacuum-concentrated using a rotary evaporator to remove the organic solvent and obtain a crude product, and the obtained crude product was purified by column chromatography using ethyl acetate/petroleum ether (volume ratio 1:3) as a mobile phase and vacuum-dried at 50 ℃ to obtain Compound 16(27.00g, yield: 72.0%).
As a result:
yield: 72.0 percent.
MS:m/z=380.2(M+H+);1HNMR(400M,d6-DMSO):7.81(s,1H),7.72(s,1H),7.70(s,1H),7.49(dd,1H),7.42(dd,1H),7.31(s,1H),7.28(d,1H),7.14-7.21(m,3H),2.51(d,2H),2.37(s,3H),2.33(s,3H),2.22(m,1H),1.01(d,6H).Anal.Calcd for C27H25NO:C,85.45;H,6.64;N,3.69.Found:C,85.45;H,6.64;N,3.69。
Synthesis of compound 17:
2- (4- (2-methyldibenzofuranyl)) -4-methyl-7-isobutylquinoline (compound 16) (11.38g, 0.03mol, 3.0eq) and iridium trichloride trihydrate (3.52g, 0.01mol, 1.0eq) were placed in a three-necked flask, 2-ethoxyethanol (66.7ml) and deionized water (33.3ml) were added, and the resulting mixture was reacted for 16hrs under a nitrogen atmosphere at about 110 ℃. Cooled to room temperature, filtered, and the filtrate was skimmed off, and the residue was dried with methanol (50 ml. times.3) and n-hexane (50 ml. times.3) in this order to give Compound 17(4.82g, yield: 48.9%) as a gray solid. The obtained compound 17 was used in the next step without purification.
Synthesis of compound CPD 22:
the dichloro bridge complex compound 17(4.93g, 2.5mmol, 1.0eq) was dissolved in 2-ethoxyethanol (25ml), anhydrous sodium carbonate (6.9g, 50mmol, 20.0eq) and 2, 8-dimethylnonane-4, 6-dione (4.6g, 25mmol, 10.0eq) were added in this order, and after the addition was completed, the mixture was reacted at 30 ℃ for 16hrs under nitrogen protection, and then cooled to room temperature. Adding 1g of C salt and 200ml of dichloromethane into the reaction solution to dissolve the product, then filtering the mixed solution through a C salt bed, filtering the filtrate through a short silica gel column to obtain a filtrate, removing most of dichloromethane, adding 30ml of isopropanol into the filtrate to precipitate a red solid, and filtering. The solid is separated by column chromatography to obtain the target complex CPD 22. (1.87g, yield: 33.01%).
Results of CPD22 yield: 33.01 percent. MS M/z 1133.5(M + H +).
Synthesis of common intermediate:
synthesis of compound 19:
compound 18(27.37g, 0.12mol, 1.2eq), 2-chloroquine (16.3g, 0.1mol, 1.0eq), Cs2CO3(97.5g, 0.3mol, 3.0eq), and Pd (dppf) Cl2(3.655g, 0.005mmol, 0.05eq) were charged in a 3L round bottom flask, 1L of anhydrous toluene was added, and stirring was refluxed at 110 ℃ for 16 hours under nitrogen. Subsequently, the mixture was cooled to room temperature, concentrated under vacuum using a rotary evaporator to remove the organic solvent, the residue was dissolved in 1L of dichloromethane, 500ml of a saturated aqueous solution of sodium carbonate was slowly added, stirred, and the layers were separated, the organic phase was washed with saturated sodium carbonate (300 ml. times.3), H2O (300 ml. times.3), and saturated sodium chloride (300 ml. times.3) in this order, dried over sodium sulfate and filtered, the filtrate was concentrated under vacuum using a rotary evaporator to remove the organic solvent and obtain a crude product, and the obtained crude product was purified by column chromatography using ethyl acetate/petroleum ether (volume ratio 1:2) as a mobile phase, and dried under vacuum at 50 ℃ to obtain Compound 19(26.7g, yield: 85.86%).
As a result:
yield: 85.86 percent.
MS:m/z=312.1(M+H+);1HNMR(400M,d6-DMSO):8.06(dd,1H),8.03(dd,1H),7.61-7.86(m,6H),7.31-7.43(m,5H).Anal.Calcd for C21H13NS:C,81.00;H,4.21;N,4.50.Found:C,81.00;H,4.22;N,4.49。
Synthesis of compound 20:
2- (4-Dibenzothiophene) quinoline (Compound 19) (9.33g, 0.03mol, 3.0eq) and iridium trichloride trihydrate (3.52g, 0.01mol, 1.0eq) were placed in a three-necked flask, and 2-ethoxyethanol (66.7ml) and deionized water (33.3ml) were added to react the resulting mixture at about 110 ℃ for 16hrs under nitrogen protection. Cooled to room temperature, filtered, and the filtrate was skimmed off, and the residue was dried with methanol (50 ml. times.3) and n-hexane (50 ml. times.3) in this order to give compound 20(5.53g, yield: 65.2%) as a gray solid. The obtained compound 20 was used in the next step without purification.
EXAMPLE 13 Synthesis of Compound CPD25
The dichloro bridge complex compound 20(4.24g, 2.5mmol, 1.0eq) was dissolved in 2-ethoxyethanol (25ml), anhydrous sodium carbonate (6.9g, 50mmol, 20.0eq) and acetylacetone (2.5g, 25mmol, 10.0eq) were added in this order, and after the addition was completed, the reaction was carried out at 30 ℃ for 16hrs under nitrogen protection, and then cooled to room temperature. 1g C salt and 200ml dichloromethane are added into the reaction solution to dissolve the product, then the mixed solution is filtered through a C salt bed, the filtrate is filtered through a short silica gel column, most dichloromethane is removed from the obtained filtrate, 30ml isopropanol is added into the filtrate, a red solid is separated out, and the red solid is filtered. The solid is separated by column chromatography to obtain the target complex CPD 25. (2.01g, yield: 43.9%).
Results of CPD25 yield: 43.9 percent. MS M/z 913.2(M + H +).
EXAMPLE 14 Synthesis of Compound CPD26
The dichloro bridge complex compound 20(4.24g, 2.5mmol, 1.0eq) was dissolved in 2-ethoxyethanol (25ml), anhydrous sodium carbonate (6.9g, 50mmol, 20.0eq) and 2, 8-dimethylnonane-4, 6-dione (4.6g, 25mmol, 10.0eq) were added in this order, and after the addition was completed, the mixture was reacted at 30 ℃ for 16hrs under nitrogen protection, and then cooled to room temperature. Adding 1g of C salt and 200ml of dichloromethane into the reaction solution to dissolve the product, then filtering the mixed solution through a C salt bed, filtering the filtrate through a short silica gel column to obtain a filtrate, removing most of dichloromethane, adding 30ml of isopropanol into the filtrate to precipitate a red solid, and filtering. The solid is separated by column chromatography to obtain the target complex CPD 26. (1.98g, yield: 39.8%).
Results of CPD26 yield: 39.8 percent. MS M/z 997.3(M + H +).
EXAMPLE 15 Synthesis of Compound CPD27
The dichloro bridge complex compound 20(4.24g, 2.5mmol, 1.0eq) was dissolved in 2-ethoxyethanol (25ml), anhydrous sodium carbonate (6.9g, 50mmol, 20.0eq) and 2-acetylphenol (3.4g, 25mmol, 10.0eq) were added in this order, and after the addition was completed, the mixture was reacted at 30 ℃ for 16hrs under nitrogen protection, and then cooled to room temperature. 1g C salt and 200ml dichloromethane are added into the reaction solution to dissolve the product, then the mixed solution is filtered through a C salt bed, the filtrate is filtered through a short silica gel column, most dichloromethane is removed from the obtained filtrate, 30ml isopropanol is added into the filtrate, a red solid is separated out, and the red solid is filtered. The solid is separated by column chromatography to obtain the target complex CPD 27. (1.59g, yield: 33.5%).
Results of CPD27 yield: 33.5 percent. MS M/z 949.2(M + H +).
EXAMPLE 16 Synthesis of Compound CPD28
The first step is as follows: synthesis of triflate
Dimer compound 20(33.93g, 0.02mol, 1.0eq) was dissolved in 1L of dichloromethane, to which was added silver trifluoromethanesulfonate (10.5g, 0.04mol, 2.0eq) and isopropanol (75ml) in that order. The mixture was stirred at room temperature overnight. The silver chloride was filtered off and the filtrate was spin dried to give 42g of product, which was used in the next reaction without purification.
The second step is that: synthesis of Compound CPD28
The product of the first step (22.0g, 0.02mol, 1.0eq) and 2-phenylpyridine (9.3g, 0.06mol, 3.0eq) were dissolved in 200ml of anhydrous ethanol, and the mixture was heated under reflux overnight under a nitrogen atmosphere. After the reaction solution was cooled to room temperature, the precipitate was filtered and washed with methanol and n-hexane in sequence for 3 times. After drying at 50 ℃ in vacuo, the title compound CPD28(13.42g, 69.4% yield) was obtained. The dried CPD28 was used directly for sublimation purification to afford CPD28(9.8g, 73.03% yield) as a pure sublimation target compound.
The corresponding compounds of other general formulas such as formula I, formula II, formula IV, formula V, formula VI and formula VII can be synthesized by the same similar method, and only the corresponding raw materials are selected.
Application example:
preparation of organic electroluminescent device
A glass substrate with an ITO transparent electrode having a thickness of 25 mm. times.75 mm. times.1.1 mm was ultrasonically washed in isopropyl alcohol for 5 minutes, and then subjected to ozone washing for 30 minutes. The thickness of the ITO film was set to 100 nm. The washed glass substrate with the transparent electrode line was mounted on a substrate holder of a vacuum deposition apparatus, and first, compound HATCN was deposited on the surface of the substrate on the side having the transparent electrode line so as to cover the transparent electrode, thereby forming a compound HATCN film having a thickness of 10nm, which film functions as a hole injection layer and also functions to planarize ITO. Then, HIL2 was vapor-deposited on the HATCN to form a film thickness of 125nm as a hole injecting material, and then, after completion of the evaporation of HIL2, HTM was vapor-deposited thereon to form a film thickness of 25nm as a hole transporting material. A light-emitting layer having a thickness of 25nm was formed by co-depositing Host and a dopant compound (corresponding to Cpd-X) on the HTM film, and the dopant material concentration was 10%. ETL as an electron transport material was deposited on the light-emitting layer to form an electron transport layer having a thickness of 20 nm. LiF is vapor-deposited on the electron transport layer to form a LiF layer having a film thickness of 1 nm. Metal Al was evaporated on LiF to form a metal cathode having a film thickness of 80 nm. The structure of the organic electroluminescent device is represented by a simple formula as follows: ITO (100nm)/HATCN (10nm)/HIL2(125nm)/HTM (25nm)/EML (Host: Dopantt ═ 90:10, 25nm)/ETL (20nm)/LiF (1nm)/Al (80 nm).
The devices fabricated as described above were subjected to performance testing, and the results are shown in table 1 below.
TABLE 1
Guest material | Voltage/V | Cd/A | Lm/W | CIEx | CIEy | LT90@1000nits |
Cpd1 | 4.3 | 21 | 15.33 | 0.663 | 0.315 | 180 |
Cpd2 | 4.6 | 23 | 15.70 | 0.668 | 0.310 | 220 |
Cpd3 | 4.4 | 20 | 14.27 | 0.663 | 0.325 | 164 |
Cpd4 | 4.3 | 22 | 16.07 | 0.665 | 0.318 | 260 |
Cpd5 | 4.5 | 22 | 15.35 | 0.665 | 0.309 | 198 |
Cpd6 | 4.3 | 23 | 16.80 | 0.668 | 0.305 | 220 |
Cpd7 | 4.4 | 21 | 14.99 | 0.665 | 0.318 | 146 |
Cpd8 | 4.2 | 20 | 14.95 | 0.668 | 0.312 | 260 |
Cpd9 | 4.1 | 24 | 18.38 | 0.665 | 0.318 | 258 |
Cpd13 | 4.2 | 26 | 19.44 | 0.668 | 0.312 | 280 |
Cpd18 | 4.2 | 25 | 18.69 | 0.668 | 0.302 | 292 |
Cpd22 | 4.2 | 26 | 19.44 | 0.669 | 0.302 | 300 |
Cpd25 | 4.3 | 21 | 15.33 | 0.661 | 0.313 | 169 |
Cpd26 | 4.6 | 22 | 15.02 | 0.663 | 0.315 | 209 |
Cpd27 | 4.4 | 21 | 14.99 | 0.664 | 0.322 | 158 |
Cpd28 | 4.3 | 21 | 15.33 | 0.665 | 0.319 | 229 |
Comparative Cpd | 5.3 | 14 | 8.29 | 0.660 | 0.330 | 108 |
As can be seen from the test results in table 1, the material of the present invention has not only higher luminous efficiency, but also more saturated red color scale, and the device lifetime is superior to that of the comparative example.
The results show that the metal complex designed by the invention is used as a guest material, and can convert triplet excitation energy into luminescence, so that the metal complex is applied to display devices such as organic electroluminescence and the like, the luminous efficiency of the devices can be improved, and the energy consumption can be reduced.
The applicant states that the present invention is illustrated by the above examples to show the detailed process equipment and process flow of the present invention, but the present invention is not limited to the above detailed process equipment and process flow, i.e. it does not mean that the present invention must rely on the above detailed process equipment and process flow to be implemented. It should be understood by those skilled in the art that any modification of the present invention, equivalent substitutions of the raw materials of the product of the present invention, addition of auxiliary components, selection of specific modes, etc., are within the scope and disclosure of the present invention.
Claims (15)
1. A compound using quinolyl dibenzo substitution as a ligand has a structure shown in formula I:
wherein,
z is selected from O, S, CR2, NR or Se, wherein R is alkyl, heteroalkyl, aryl or heteroaryl;
R1,R2,R3,R4are independently selected fromFrom hydrogen, alkyl, heteroalkyl, aryl or heteroaryl;
m is a metal;
X-Y is a monoanionic bidentate ligand;
the sum of a and b is the valence of the metal ion.
2. The compound of claim 1, wherein said compound has the following formula II:
3. a compound according to claim 1 or 2, wherein R is1,R2,R3Each independently is hydrogen, mono-, di-or poly-substituted, preferably mono-substituted.
4. A compound according to claim 1 or 2, wherein R is4Independently hydrogen or mono-or di-or polysubstituted, preferably hydrogen.
5. A compound according to claim 1 or 2, wherein R is1,R2Independently a substituent or a fused ring structure with the parent.
6. A compound according to claim 1 or 2, wherein R is1,R2,R3Independently an electron donating alkyl or heteroalkyl group of no more than four carbon atoms, preferably an electron donating branched alkyl group containing no more than 4 carbon atoms.
7. A compound according to claim 1 or 2, wherein R is3The substitution position of (b) is an adjacent position of a metal-carbon bond.
8. A compound according to claim 1 or 2, wherein R is3The substitution position of (b) is the relative position of the metal-carbon bond.
9. Compound according to claim 1 or 2, characterized in that M is a metal with an atomic coefficient greater than 40, preferably Cu, Pt, Pd, Os or Ir, more preferably Pt or Ir, especially Ir.
10. A compound according to claim 1 or 2, wherein X-Y is different from the left ligand.
11. A compound according to claim 1 or 2, characterized in that X-Y is a 1, 3-diketone.
12. The compound of claim 1 or 2, wherein the compound is of the structure:
13. the compound of claim 1 or 2, wherein the compound is of the structure:
14. an OLED phosphorescent guest material comprising a compound according to any one of claims 1 to 13.
15. An OLED device comprising a compound according to any one of claims 1 to 13.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610918184.9A CN107973823A (en) | 2016-10-21 | 2016-10-21 | The electroluminescent organic material of a kind of quinolyl dibenzo substitution as ligand and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610918184.9A CN107973823A (en) | 2016-10-21 | 2016-10-21 | The electroluminescent organic material of a kind of quinolyl dibenzo substitution as ligand and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107973823A true CN107973823A (en) | 2018-05-01 |
Family
ID=62003676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610918184.9A Pending CN107973823A (en) | 2016-10-21 | 2016-10-21 | The electroluminescent organic material of a kind of quinolyl dibenzo substitution as ligand and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107973823A (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109593105A (en) * | 2018-12-21 | 2019-04-09 | 北京诚志永华显示科技有限公司 | Metal complex, organic electroluminescence device, electroluminescent organic material |
WO2019093369A1 (en) * | 2017-11-07 | 2019-05-16 | 三菱ケミカル株式会社 | Iridium complex compound, composition containing said compound and solvent, organic electroluminescent element containing said compound, display device, and illumination device |
CN110317187A (en) * | 2019-07-26 | 2019-10-11 | 北京燕化集联光电技术有限公司 | A kind of organic host material and the preparation method and application thereof |
WO2019221484A1 (en) * | 2018-05-14 | 2019-11-21 | 주식회사 엘지화학 | Organometallic compound and organic light emitting diode comprising same |
WO2020134570A1 (en) * | 2018-12-27 | 2020-07-02 | 广东阿格蕾雅光电材料有限公司 | Organic metal compound and application thereof |
WO2020158689A1 (en) * | 2019-01-30 | 2020-08-06 | 田中貴金属工業株式会社 | Organic iridium complex for organic electroluminescent element |
CN112341500A (en) * | 2020-11-12 | 2021-02-09 | 马鞍山南大高新技术研究院有限公司 | Iridium complex with main ligand containing carbazolyl and application |
CN112830943A (en) * | 2019-11-25 | 2021-05-25 | 广东阿格蕾雅光电材料有限公司 | Compound and application thereof |
CN113683643A (en) * | 2020-05-19 | 2021-11-23 | 北京夏禾科技有限公司 | Organic luminescent material |
DE102021112841A1 (en) | 2020-05-19 | 2021-11-25 | Beijing Summer Sprout Technology Co., Ltd. | Organic, light-emitting material |
WO2021258875A1 (en) * | 2020-06-23 | 2021-12-30 | 广东阿格蕾雅光电材料有限公司 | Metal iridium complex and use thereof |
CN114394999A (en) * | 2022-03-01 | 2022-04-26 | 冠能光电材料(深圳)有限责任公司 | Organic metal iridium complex, electroluminescent material and application thereof |
CN114656506A (en) * | 2020-12-22 | 2022-06-24 | 乐金显示有限公司 | Organometallic compound, organic light emitting diode and organic light emitting device having the same |
WO2022262309A1 (en) * | 2021-06-18 | 2022-12-22 | 广东阿格蕾雅光电材料有限公司 | Organometallic iridium compound and application thereof |
WO2023051134A1 (en) * | 2021-09-28 | 2023-04-06 | 四川阿格瑞新材料有限公司 | Metal iridium complex and application thereof |
WO2023063112A1 (en) * | 2021-10-11 | 2023-04-20 | キヤノン株式会社 | Organic compound and organic light-emitting element |
WO2023065614A1 (en) * | 2021-10-18 | 2023-04-27 | 广州华睿光电材料有限公司 | Metal complex, mixture, composition, and organic electronic component |
DE112021004918T5 (en) | 2020-12-04 | 2023-07-13 | Guangdong Aglaia Optoelectronic Materials Co., Ltd. | METAL COMPLEX AND ITS APPLICATION |
DE112021005110T5 (en) | 2020-12-04 | 2023-07-20 | Guangdong Aglaia Optoelectronic Materials Co., Ltd. | Ruthenium complex and its application |
CN114656506B (en) * | 2020-12-22 | 2024-10-22 | 乐金显示有限公司 | Organometallic compound, organic light emitting diode having the same, and organic light emitting device |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1696137A (en) * | 2005-04-30 | 2005-11-16 | 中国科学院长春应用化学研究所 | Complexes of red light iridium by using nitrogen heterocycles in quinoline as ligand, and application |
CN1802382A (en) * | 2003-06-09 | 2006-07-12 | 日立化成工业株式会社 | Metal coordination compound, polymer composition, and organic electroluminescence element using them |
JP2013155153A (en) * | 2012-01-31 | 2013-08-15 | Osaka Prefecture Univ | Carbazole derivative, host material for organic electroluminescent element, and organic electroluminescent element |
CN104629741A (en) * | 2013-11-14 | 2015-05-20 | 海洋王照明科技股份有限公司 | Organic electrophosphorescence material, as well as preparation method and organic electroluminescent device thereof |
-
2016
- 2016-10-21 CN CN201610918184.9A patent/CN107973823A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1802382A (en) * | 2003-06-09 | 2006-07-12 | 日立化成工业株式会社 | Metal coordination compound, polymer composition, and organic electroluminescence element using them |
CN1696137A (en) * | 2005-04-30 | 2005-11-16 | 中国科学院长春应用化学研究所 | Complexes of red light iridium by using nitrogen heterocycles in quinoline as ligand, and application |
JP2013155153A (en) * | 2012-01-31 | 2013-08-15 | Osaka Prefecture Univ | Carbazole derivative, host material for organic electroluminescent element, and organic electroluminescent element |
CN104629741A (en) * | 2013-11-14 | 2015-05-20 | 海洋王照明科技股份有限公司 | Organic electrophosphorescence material, as well as preparation method and organic electroluminescent device thereof |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2019093369A1 (en) * | 2017-11-07 | 2021-01-14 | 三菱ケミカル株式会社 | Iridium complex compound, composition containing the compound and solvent, organic electroluminescent device containing the compound, display device and lighting device. |
WO2019093369A1 (en) * | 2017-11-07 | 2019-05-16 | 三菱ケミカル株式会社 | Iridium complex compound, composition containing said compound and solvent, organic electroluminescent element containing said compound, display device, and illumination device |
JP7238782B2 (en) | 2017-11-07 | 2023-03-14 | 三菱ケミカル株式会社 | Iridium complex compound, composition containing said compound and solvent, organic electroluminescence device containing said compound, display device and lighting device |
WO2019221484A1 (en) * | 2018-05-14 | 2019-11-21 | 주식회사 엘지화학 | Organometallic compound and organic light emitting diode comprising same |
CN111655705B (en) * | 2018-05-14 | 2023-11-07 | 株式会社Lg化学 | Organometallic compound and organic light emitting device including the same |
CN111655705A (en) * | 2018-05-14 | 2020-09-11 | 株式会社Lg化学 | Organometallic compound and organic light emitting device including the same |
CN109593105A (en) * | 2018-12-21 | 2019-04-09 | 北京诚志永华显示科技有限公司 | Metal complex, organic electroluminescence device, electroluminescent organic material |
WO2020134570A1 (en) * | 2018-12-27 | 2020-07-02 | 广东阿格蕾雅光电材料有限公司 | Organic metal compound and application thereof |
CN113396152A (en) * | 2019-01-30 | 2021-09-14 | 田中贵金属工业株式会社 | Organic iridium complex for organic electroluminescent element |
JP2020121936A (en) * | 2019-01-30 | 2020-08-13 | 田中貴金属工業株式会社 | Organic iridium complex for organic electroluminescent element |
WO2020158689A1 (en) * | 2019-01-30 | 2020-08-06 | 田中貴金属工業株式会社 | Organic iridium complex for organic electroluminescent element |
DE112020000607B4 (en) | 2019-01-30 | 2024-05-29 | Tanaka Kikinzoku Kogyo K.K. | Organoiridium complex for organic electroluminescent element |
JP7195952B2 (en) | 2019-01-30 | 2022-12-26 | 田中貴金属工業株式会社 | Organic iridium complexes for organic electroluminescent devices |
CN110317187B (en) * | 2019-07-26 | 2022-01-14 | 北京燕化集联光电技术有限公司 | Organic main body material and preparation method and application thereof |
CN110317187A (en) * | 2019-07-26 | 2019-10-11 | 北京燕化集联光电技术有限公司 | A kind of organic host material and the preparation method and application thereof |
DE112020004791T5 (en) | 2019-11-25 | 2022-06-15 | Guangdong Aglaia Optoelectronic Materials Co., Ltd. | connection and its application |
WO2021103770A1 (en) * | 2019-11-25 | 2021-06-03 | 广东阿格蕾雅光电材料有限公司 | Compound and application thereof |
CN112830943A (en) * | 2019-11-25 | 2021-05-25 | 广东阿格蕾雅光电材料有限公司 | Compound and application thereof |
CN112830943B (en) * | 2019-11-25 | 2022-12-23 | 广东阿格蕾雅光电材料有限公司 | Compound and application thereof |
DE102021112841A1 (en) | 2020-05-19 | 2021-11-25 | Beijing Summer Sprout Technology Co., Ltd. | Organic, light-emitting material |
JP2021191744A (en) * | 2020-05-19 | 2021-12-16 | 北京夏禾科技有限公司 | Organic light emitting material |
CN113683643A (en) * | 2020-05-19 | 2021-11-23 | 北京夏禾科技有限公司 | Organic luminescent material |
DE102021112841A9 (en) | 2020-05-19 | 2022-03-17 | Beijing Summer Sprout Technology Co., Ltd. | Organic light emitting material |
JP7530645B2 (en) | 2020-05-19 | 2024-08-08 | 北京夏禾科技有限公司 | Organic Light Emitting Materials |
WO2021258875A1 (en) * | 2020-06-23 | 2021-12-30 | 广东阿格蕾雅光电材料有限公司 | Metal iridium complex and use thereof |
CN112341500A (en) * | 2020-11-12 | 2021-02-09 | 马鞍山南大高新技术研究院有限公司 | Iridium complex with main ligand containing carbazolyl and application |
DE112021004918T5 (en) | 2020-12-04 | 2023-07-13 | Guangdong Aglaia Optoelectronic Materials Co., Ltd. | METAL COMPLEX AND ITS APPLICATION |
DE112021005110T5 (en) | 2020-12-04 | 2023-07-20 | Guangdong Aglaia Optoelectronic Materials Co., Ltd. | Ruthenium complex and its application |
JP7323589B2 (en) | 2020-12-22 | 2023-08-08 | エルジー ディスプレイ カンパニー リミテッド | Organometallic compounds and organic light-emitting diodes and organic light-emitting devices containing the same |
JP2022099248A (en) * | 2020-12-22 | 2022-07-04 | エルジー ディスプレイ カンパニー リミテッド | Organic metal compound, and organic light-emitting diode, and organic light-emitting device comprising the same |
CN114656506A (en) * | 2020-12-22 | 2022-06-24 | 乐金显示有限公司 | Organometallic compound, organic light emitting diode and organic light emitting device having the same |
CN114656506B (en) * | 2020-12-22 | 2024-10-22 | 乐金显示有限公司 | Organometallic compound, organic light emitting diode having the same, and organic light emitting device |
WO2022262309A1 (en) * | 2021-06-18 | 2022-12-22 | 广东阿格蕾雅光电材料有限公司 | Organometallic iridium compound and application thereof |
WO2023051134A1 (en) * | 2021-09-28 | 2023-04-06 | 四川阿格瑞新材料有限公司 | Metal iridium complex and application thereof |
WO2023063112A1 (en) * | 2021-10-11 | 2023-04-20 | キヤノン株式会社 | Organic compound and organic light-emitting element |
WO2023065614A1 (en) * | 2021-10-18 | 2023-04-27 | 广州华睿光电材料有限公司 | Metal complex, mixture, composition, and organic electronic component |
CN114394999B (en) * | 2022-03-01 | 2024-01-16 | 冠能光电材料(深圳)有限责任公司 | Organic metal iridium complex, electroluminescent material and application thereof |
CN114394999A (en) * | 2022-03-01 | 2022-04-26 | 冠能光电材料(深圳)有限责任公司 | Organic metal iridium complex, electroluminescent material and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107973823A (en) | The electroluminescent organic material of a kind of quinolyl dibenzo substitution as ligand and application thereof | |
JP7011333B2 (en) | Organic luminescent material containing a novel co-ligand | |
CN101679852B (en) | Compound for organic electroluminescent device and organic electroluminescent device | |
CN111377969B (en) | Organic metal compound and application thereof | |
EP1499624B1 (en) | Electroluminescent materials | |
CN101679438B (en) | Compound for organic electroluminescent device and organic electroluminescent device | |
JP5009922B2 (en) | Organic electroluminescent element material and organic electroluminescent element | |
KR20130084615A (en) | Novel heteroleptic iridium complexes | |
JP2013526014A (en) | Novel organic electroluminescent compound and organic electroluminescent device using the same | |
KR20110116635A (en) | Novel organic electroluminescent compounds and organic electroluminescent device using the same | |
CN102703059A (en) | Phosphorescent luminescent materials and preparation method and application thereof | |
CN109593097B (en) | Phosphorescent host compound and organic electroluminescent device using same | |
CN110330481B (en) | Red phosphorescent compound and organic light-emitting device using same | |
KR20210093180A (en) | Metal complex, electroluminescent device including the same, and use thereof | |
CN107266503A (en) | A kind of organometallic complex as electroluminescent organic material | |
CN109810146B (en) | Green phosphorescent compound and organic electroluminescent device using the same | |
CN107021987A (en) | A kind of tetradentate ligandses Pt complex compounds of unit based on miscellaneous nitrogen fluorenes for OLED material | |
CN111116673A (en) | Red phosphorescent compound and organic electroluminescent device using the same | |
CN106939024A (en) | A kind of tetradentate ligandses Pt complex compounds of unit based on miscellaneous nitrogen fluorenes for OLED material | |
JP2008288254A (en) | Organic el element | |
KR20150017708A (en) | Blue luminescent compounds | |
CN107266502A (en) | A kind of organometallic complex as electroluminescent organic material | |
CN111423447A (en) | Red phosphorescent compound and organic light-emitting device | |
CN108059644A (en) | The electroluminescent organic material of a kind of naphthalene azepine dibenzo substitution as ligand and application thereof | |
KR20140145672A (en) | Organic compounds and organic electro luminescence device comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180501 |